Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Atea Pharmaceuticals (AVIR) Tax Rate (2021 - 2026)

Atea Pharmaceuticals' Tax Rate history spans 6 years, with the latest figure at 0.11% for Q1 2026.

  • Quarterly Tax Rate rose 49.0% to 0.11% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 3.59% through Mar 2026, up 424.0% year-over-year, with the annual reading at 3.75% for FY2025, 430.0% up from the prior year.
  • Tax Rate came in at 0.11% for Q1 2026, down from 13.11% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 32.21% in Q3 2022 to a low of 0.9% in Q4 2023.
  • The 5-year median for Tax Rate is 0.56% (2025), against an average of 2.34%.
  • The largest YoY upside for Tax Rate was 5982bps in 2022 against a maximum downside of -8277bps in 2022.
  • Atea Pharmaceuticals' Tax Rate stood at 0.36% in 2022, then plummeted by -151bps to 0.9% in 2023, then rose by 25bps to 0.68% in 2024, then soared by 2041bps to 13.11% in 2025, then tumbled by -101bps to 0.11% in 2026.
  • Per Business Quant, the three most recent readings for AVIR's Tax Rate are 0.11% (Q1 2026), 13.11% (Q4 2025), and 0.47% (Q3 2025).